1.
Zerga M. Bispecific antibodies in the treatment of relapsed/refractory diffuse large B cell lymphoma. Role of epcoritamab. RH [Internet]. 2025 Jun. 4 [cited 2026 Nov. 18];29(1):11-2. Available from: https://mail.revistahematologia.com.ar/index.php/Revista/article/view/639